title: Soluble HLA class I antigens in patients with type I diabetes and their family members.
abstract: Our objective was to study a possible contribution of MHC genes to S-HLA-I secretion in patients with Type I diabetes. Quantitatively, we used a highly sensitive enzyme-linked immunoassay to measure S-HLA-I in the serum of a total of 39 patients with Type I diabetes, as well as 36 kinships of 12 diabetic patients and 82 normal individuals with known HLA-phenotypes. S-HLA-I levels were abnormally elevated in patients or their non-diabetic relatives compared to normal controls (p < 0.0009). No complete HLA-haplotype had been identified to be correlated with high or low S-HLA-I secretion. Only the HLA-A23 or A24 (splits of HLA-A9) positive individuals sera were found to contain high S-HLA-I concentrations in all populations studied. The difference in S-HLA-I levels of HLA-A24 patients (n = 4) or their HLA-A24 positive non-diabetic relatives (n = 10) to the group of HLA-A24 normal controls (n = 15) was statistically highly significant (p < 0.0005 and p < 0.0009, respectively). The results suggests that HLA-A24 may confer additional independent risk for the disease expression in male children but not in female siblings. Nevertheless, the data implies that the patients or their non-diabetic relatives carrying the HLA-A24 have increased risk of developing ICA associated with high S-HLA-I levels compared to HLA-A24 negative probands or their kinships with low levels of S-HLA-I. This effect occurred irrespective to other diabetes related HLA-DR alleles. In summary, the results show a pronounced genetic heterogeneity of Type I diabetes with MHC control of the expression of S-HLA-I and possible involvement of hormonal factors that might potentiate a specific synthesis of S-HLA-I. The findings have implications for identifying individuals with a possible risk for developing the disease.
authors.affiliation: Department of Surgery, Louisiana State University Medical Center, Shreveport 71130, USA.
authors.forename: I
authors.initials: I
authors.lastname: Adamashvili
authors.forename: R
authors.initials: R
authors.lastname: McVie
authors.forename: F
authors.initials: F
authors.lastname: Gelder
authors.forename: M
authors.initials: M
authors.lastname: Gautreaux
authors.forename: J
authors.initials: J
authors.lastname: Jaramillo
authors.forename: T
authors.initials: T
authors.lastname: Roggero
authors.forename: J
authors.initials: J
authors.lastname: McDonald
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D005260:Female; D014644:Genetic Variation; D015395:Histocompatibility Antigens Class I / Q000097:blood*; D006801:Humans; D008297:Male
chemical_list: D015395:Histocompatibility Antigens Class I